Spencer Pharmaceutical Inc. announced today that an independent laboratory has been mandated to validate the met4 findings.
According to the mandate, the independent laboratory will perform the animal testing to validate the release time and efficiency of the new Spencer met4 formulation.
"Management believes that the independent laboratory will significantly increase the visibility of Spencer. These tests are straightforward and can be accomplished over the next month or so," stated Dr. Max Arella, President of Spencer Pharmaceutical Inc. Furthermore, "Tests are not only necessary but may help us in adding value to future licensing deals and can potentially provide significant revenue stream for the company in the near and long term while creating significant share hold value."
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
No comments:
Post a Comment